Windlas Biotech IPO opens on August 4 and closes on August 6. Demat account, trading application and UPI ID are mandatory if you are applying for an initial public offering (IPO). Windlas Biotech ...
Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001. The Company convertedfrom a Private Limited Company to a Public Limited Company and the name ...
A bullish pole flag pattern on the weekly time frame seems to have completed its throwback near 61.80 percent Fibonacci retracement and the uptrend is most likely to stretch the prices further ...
Windlas Biotech Ltd share price was down by -6.44% from the previous closing price of ₹971.35. Who are peers of Windlas Biotech Ltd? The peers of Windlas Biotech Ltd are Sun Pharmaceuticals ...
Windlas Biotech Limited, a leading Indian pharmaceutical CDMO, announced today that its new injectable manufacturing facility has received Good Manufacturing Practices (GMP) certification from ...
Shares of Windlas Biotech listed at ₹439 while the price band was fixed at ₹448-460 per share. The IPO was subscribed 22.56 times on the last day of the bidding. The market capitalisation of ...
Learn about Windlas Biotech Limited in Dehradun, Uttarakhand.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
IPO-bound Windlas Biotech plans to build CDMO injectable biz, trade generics Hitech Windlas, Managing Director of Windlas Biotech in an interview to Moneycontrol said the company plans to use ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Find Windlas Biotech Ltd. Technical Chart BSE Analysis on The Economic Times. Get Windlas Biotech Ltd. Technical Charts Real-time and intraday charts, Windlas Biotech Ltd. Stock Analysis, and more.